Research on clinical manifestations and signs and its evolution law of phlegm and blood stasis syndrome in the coronary heart disease
|
注册号: Registration number: |
ChiCTR-OOC-15006599 |
|
最近更新日期: Date of Last Refreshed on: |
2015-06-17 16:48:23 |
|
注册时间: Date of Registration: |
2015-06-16 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
冠心病痰瘀互结证临床表征及其演变规律研究 |
|
Public title: |
Research on clinical manifestations and signs and its evolution law of phlegm and blood stasis syndrome in the coronary heart disease |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
冠心病痰瘀互结证临床表征及其演变规律研究 |
|
Scientific title: |
Research on clinical manifestations and signs and its evolution law of phlegm and blood stasis syndrome in the coronary heart disease |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
彭丹虹 |
研究负责人: |
李先涛 |
|
Applicant: |
Peng Dan-hong |
Study leader: |
Li Xian-tao |
|
申请注册联系人电话: Applicant telephone: |
+86 13434100760 |
研究负责人电话: Study leader's telephone: |
+86 18620493495 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
429532047@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
lixiantao@gzucm.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广州市番禺区广州大学城外环东路232号广州中医药大学 |
研究负责人通讯地址: |
广州市番禺区广州大学城外环东路232号广州中医药大学 |
|
Applicant address: |
Guangzhou University of Chinese Medicine, 232 Outer ring east road, Guangzhou University Mega center, Panyu District, Guangzhou, China |
Study leader's address: |
Guangzhou University of Chinese Medicine, 232 Outer ring east road, Guangzhou University Mega center, Panyu District, Guangzhou, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
广州中医药大学基础医学院 |
||
|
Applicant's institution: |
college of Basic Medical Science of Guangzhou University of Chinese Medicine |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
TJUTCM-EC2015000 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
天津中医药大学医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Tianjin University of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2015-05-29 00:00:00 |
||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
广州中医药大学 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Guangzhou University of Chinese Medicine |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广州市番禺区广州大学城外环东路232号广州中医药大学 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
Guangzhou University of Chinese Medicine, 232 Outer ring east road, Guangzhou University Mega center, Panyu District, Guangzhou, China |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
国家科学技术部 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Ministry of Science and Technology, China |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Stable angina pectoris of coronary heart disease |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
在研究冠心病痰瘀互结证候分布规律的基础上,通过纵向追踪临床现场调查,揭示冠心病痰瘀互结证的临床表征及其演变规律。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
Based on the study of the distribution of phlegm and blood stasis syndromes in the coronary heart disease, the clinical characteristics and the evolution of phlegm and blood stasis syndrome in the coronary heart disease are revealed by longitudinal tracing of the clinical investigation. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
1.西医诊断标准 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
1. Diagnostic criteria of western medicine: |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1.冠心病不稳定性心绞痛; |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1. Unstable angina of coronary heart disease; |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2016-01-01 00:00:00至 To 2018-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2016-01-01 00:00:00 至 To 2018-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
|
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
|
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
|
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
|
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
|
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |